APTOSE BIOSCIENCES INC/ CA03835T3091 /
17.05.2024 21:59:47 | Изменение -0.02 | Объем сделки | Бид22:00:17 | Предложение22:00:17 | Максимум | Минимум |
---|---|---|---|---|---|---|
1.61CAD | -1.23% | 12,500 Оборот: 20,044 |
1.60Величина цены спроса: 3,200 | 1.65Величина цены предложения: 300 | 1.63 | 1.58 |
GlobeNewswire
23:15
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
23:03
Experience the Illicit Romance of 19th-Century with B.D. Anderson's "Forbidden Desires"
GlobeNewswire
23:00
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Servic...
GlobeNewswire
23:00
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
22:48
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors wit...
GlobeNewswire
22:42
MERGER INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Avangrid, Inc. (A...
GlobeNewswire
22:35
Breaking News: AthenaDexFi Launches Exciting Pre-Sale for ATH Token, Unveiling Lucrative Investment ...
GlobeNewswire
22:33
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
GlobeNewswire
22:30
Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Fi...
GlobeNewswire
22:30
Primech Holdings Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price...
GlobeNewswire
22:16
Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP agilon health, inc. Shareholders of Securitie...
GlobeNewswire
22:13
Saxena White P.A. Files Securities Fraud Class Action Against Vestis Corporation
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница